These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6122090)

  • 1. Steno Study Group trial of continuous subcutaneous insulin.
    Berger M; Sonnenberg G; Chantelau EA
    Lancet; 1982 Apr; 1(8276):860. PubMed ID: 6122090
    [No Abstract]   [Full Text] [Related]  

  • 2. [Continuous subcutaneous insulin infusion].
    Iwaoka H; Makino H; Yoshida S
    Nihon Rinsho; 1989 Nov; 47(11):2577-82. PubMed ID: 2601069
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.
    Hsia E; Seggelke S; Gibbs J; Hawkins RM; Cohlmia E; Rasouli N; Wang C; Kam I; Draznin B
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3132-7. PubMed ID: 22685233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.
    Rabbone I; Barbetti F; Marigliano M; Bonfanti R; Piccinno E; Ortolani F; Ignaccolo G; Maffeis C; Confetto S; Cerutti F; Zanfardino A; Iafusco D
    Acta Diabetol; 2016 Aug; 53(4):559-65. PubMed ID: 26831749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of brittle diabetic patients unresponsive to optimized subcutaneous insulin therapy (continuous subcutaneous insulin infusion).
    Pickup J; Williams G; Johns P; Keen H
    Diabetes Care; 1983; 6(3):279-84. PubMed ID: 6409572
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of insulin-dependent diabetes by continuous subcutaneous infusion of insulin (author's transl)].
    Buysschaert M; Lejeune M; Lambert AE
    Ann Endocrinol (Paris); 1981; 42(3):293-4. PubMed ID: 7316465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of the artificial endocrine pancreas in the clinic].
    Tsanev A; Zlateva S; Khristov V; Petkova M
    Vutr Boles; 1985; 24(6):107-11. PubMed ID: 4095982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic control in pregnant diabetic women using a continuous subcutaneous insulin infusion pump.
    Cohen AW; Liston RM; Mennuti MT; Gabbe SG
    J Reprod Med; 1982 Oct; 27(10):651-4. PubMed ID: 7175835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin pump therapy (continuous subcutaneous insulin infusion).
    White RD
    Prim Care; 2007 Dec; 34(4):845-71, vii. PubMed ID: 18061820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study.
    Renard E; Guerci B; Leguerrier AM; Boizel R;
    Diabetes Technol Ther; 2010 Oct; 12(10):769-73. PubMed ID: 20809682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When to consider continuous subcutaneous insulin infusion (CSII).
    Drug Ther Bull; 1987 Apr; 25(7):25-8. PubMed ID: 3569048
    [No Abstract]   [Full Text] [Related]  

  • 12. Early-morning hyperglycemia in diabetic individuals treated with continuous subcutaneous insulin infusion.
    Geffner ME; Frank HJ; Kaplan SA; Lippe BM; Levin SR
    Diabetes Care; 1983; 6(2):135-9. PubMed ID: 6682750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of unstable diabetes by continuous subcutaneous infusion of insulin].
    Capani F; Consoli A; Guagnano T; Vitacolonna E; Sensi S
    Boll Soc Ital Biol Sper; 1981 Jul; 57(13):1424-6. PubMed ID: 7284110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Causes and the principles of treatment in insulin-dependent diabetes mellitus (type I)].
    Waldhäusl W
    Pol Tyg Lek; 1982 Dec; 37(51-52):1591-4. PubMed ID: 6763993
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous subcutaneous insulin infusion--an historical perspective.
    Skyler JS
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S5-9. PubMed ID: 20515307
    [No Abstract]   [Full Text] [Related]  

  • 16. Subcutaneous insulin order sets and protocols: effective design and implementation strategies.
    Maynard G; Wesorick DH; O'Malley C; Inzucchi SE;
    J Hosp Med; 2008 Sep; 3(5 Suppl):29-41. PubMed ID: 18951386
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion.
    American Diabetes Association
    Diabetes Care; 2003 Jan; 26 Suppl 1():S125. PubMed ID: 12502638
    [No Abstract]   [Full Text] [Related]  

  • 18. Policy statement. Continuous subcutaneous insulin infusion. American Diabetes Association.
    Diabetes; 1985 Sep; 34(9):946-7. PubMed ID: 4029514
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of transient neonatal diabetes mellitus: insulin pump or insulin glargine? Our experience.
    Passanisi S; Timpanaro T; Lo Presti D; Mammì C; Caruso-Nicoletti M
    Diabetes Technol Ther; 2014 Dec; 16(12):880-4. PubMed ID: 25437016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of diabetics with the Auto-syringe pump for the continuous infusion of insulin by the subcutaneous route].
    Costa Gil JE; Galloway JA; Wentworth SM
    Rev Clin Esp; 1982 Mar; 164(6):377-81. PubMed ID: 7051202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.